EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Current State of Dermatology Mobile Applications With Artificial Intelligence Features

Shannon Wongvibulsin, Matthew J Yan, Vartan Pahalyants, William Murphy, Roxana Daneshjou, Veronica Rotemberg

JAMA Dermatology · 01.06.2024 · 160 (6) · 646

DOI: 10.1001/jamadermatol.2024.0468 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JAMA Dermatology, erschienen am 01.06.2024. Verfasst von Shannon Wongvibulsin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, David Geffen School of Medicine at the University of California, Los Angeles. Hauptthemen laut MEDLINE: Mobile Applications, Artificial Intelligence, Dermatology, Skin Diseases. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance With advancements in mobile technology and artificial intelligence (AI) methods, there has been a substantial surge in the availability of direct-to-consumer mobile applications (apps) claiming to aid in the assessment and management of diverse skin conditions. Despite widespread patient downloads, these apps exhibit limited evidence supporting their efficacy.

Objective

To identify and characterize current English-language AI dermatology mobile apps available for download, focusing on aspects such as purpose, supporting evidence, regulatory status, clinician input, data privacy measures, and use of image data. Evidence Review In this cross-sectional study, both Apple and Android mobile app stores were systematically searched for dermatology-related apps that use AI algorithms. Each app’s purpose, target audience, evidence-based claims, algorithm details, data availability, clinician input during development, and data usage privacy policies were evaluated.

Findings

A total of 909 apps were initially identified. Following the removal of 518 duplicates, 391 apps remained. Subsequent review excluded 350 apps due to nonmedical nature, non-English languages, absence of AI features, or unavailability, ultimately leaving 41 apps for detailed analysis. The findings revealed several concerning aspects of the current landscape of AI apps in dermatology. Notably, none of the apps were approved by the US Food and Drug Administration, and only 2 of the apps included disclaimers for the lack of regulatory approval. Overall, the study found that these apps lack supporting evidence, input from clinicians and/or dermatologists, and transparency in algorithm development, data usage, and user privacy. Conclusions and Relevance This cross-sectional study determined that although AI dermatology mobile apps hold promise for improving access to care and patient outcomes, in their current state, they may pose harm due to potential risks, lack of consistent validation, and misleading user communication. Addressing challenges in efficacy, safety, and transparency through effective regulation, validation, and standardized evaluation criteria is essential to harness the benefits of these apps while minimizing risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mobile ApplicationsArtificial IntelligenceDermatologySkin DiseasesHumansCross-Sectional StudiesAlgorithms

Autor:innen und Institutionen

  • Division of Dermatology, David Geffen School of Medicine at the University of California, Los Angeles.
  • Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
  • Division of Dermatology, Washington University School of Medicine in St Louis, St Louis, Missouri.
  • Department of Dermatology and Department of Biomedical Data Sciences, Stanford Medicine, California.
  • Dermatology Services, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Associate Editor, JAMA Dermatology.

Förderung

  • NCI NIH HHS

Zitieren

APA

Wongvibulsin, S., Yan, M. J., Pahalyants, V., Murphy, W., Daneshjou, R., & Rotemberg, V. (2024). Current State of Dermatology Mobile Applications With Artificial Intelligence Features. JAMA Dermatology, 160(6), 646. https://doi.org/10.1001/jamadermatol.2024.0468

Vancouver

Wongvibulsin S, Yan MJ, Pahalyants V, Murphy W, Daneshjou R, Rotemberg V. Current State of Dermatology Mobile Applications With Artificial Intelligence Features. JAMA Dermatology. 2024;160(6):646. doi:10.1001/jamadermatol.2024.0468

BibTeX
@article{Wongvibulsin2024,
  author = {Wongvibulsin, Shannon and Yan, Matthew J and Pahalyants, Vartan and Murphy, William and Daneshjou, Roxana and Rotemberg, Veronica},
  title = {Current State of Dermatology Mobile Applications With Artificial Intelligence Features},
  journal = {JAMA Dermatology},
  year = {2024},
  volume = {160},
  number = {6},
  pages = {646},
  doi = {10.1001/jamadermatol.2024.0468}
}
Kostenlos starten →